Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0798
    +0.0005 (+0.04%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2639
    +0.0017 (+0.13%)
     
  • USD/JPY

    151.2280
    -0.1440 (-0.10%)
     
  • Bitcoin USD

    70,381.66
    -965.23 (-1.35%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Today's Research Reports on Trending Tickers: Novavax and INSYS Therapeutics

NEW YORK, NY / ACCESSWIRE / August 9, 2018 / U.S. equities were mixed on Wednesday as a result of disappointing corporate earnings combined with the latest trade news. The Dow Jones Industrial Average decreased 0.18 percent to close at 25,583.75, while the S&P 500 Index fell 0.03 percent to close at 2,857.70. The Nasdaq Composite Index climbed 0.06 percent to close at 7,888.33.

“Markets are heading into one of the slowest trading periods and it’s not surprising to see small moves in either direction in the absence of big news,” said chief market strategist, at Prudential Financial, Quincy Krosby. “With the earnings season almost over, investors will continue to react to trade-related headlines, which may take another full month before we get some news in mid-September,” Krosby added.

RDI Initiates Coverage on:

Novavax, Inc.
https://rdinvesting.com/news/?ticker=NVAX

INSYS Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=INSY

Novavax's stock moved 0.83% higher Wednesday, to close the day at $1.21. The stock recorded a trading volume of 1,952,096 shares, which was below its three months average volume of 4,187,368 shares. In the last year, Novavax's shares have traded in a range of 0.96 - 2.75. The share price has gained 26.04% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $1.36 is below its 200-day moving average of $1.77. Shares of Novavax have fallen roughly 14.18 percent in the past month and are down 2.42 percent year-to-date.

Access RDI's Novavax, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=NVAX

On Wednesday, shares of INSYS Therapeutics recorded a trading volume of 1,298,115 shares, which was above the three months average volume of 655,901 shares. The stock ended the day 17.14% higher at $7.79. The share price has fallen 44.36% from its 52 week high with a 52 week trading range of 4.10 - 14.00. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $7.38 is above its 200-day moving average of $7.32. Shares of INSYS Therapeutics have gained roughly 8.19 percent in the past month and are down 19.02 percent year-to-date.

Access RDI's INSYS Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=INSY

Our Actionable Research on Novavax, Inc. (NASDAQ:NVAX) and INSYS Therapeutics, Inc. (NASDAQ:INSY) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

Advertisement